Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

A novel artificial intelligence (AI) application capable of diagnosing endocrine cancers with speed and accuracy is being presented Sunday at ENDO 2025, the Endocrine Society's annual meeting in San ...

Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...

Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy ...

Please provide your email address to receive an email when new articles are posted on . “Endocrine therapy is the mainstay of treatment for patients with localized and metastatic ...

More than 40% of Americans with estrogen receptor (ER)-low early breast cancer did not receive endocrine therapy, analysis of a national database showed. Omitting endocrine therapy in ER-low breast ...

The human body is a complex system made up of millions of cells. The cells growth is regulated by body’s internal mechanism. Sometimes, when one or group of these cells gets damaged or mutated due to ...

Following relapse on endocrine therapy for advanced, hormone receptor-positive breast cancer, it is common for patients to experience responses to alternative endocrine agents. Fulvestrant (‘Faslodex’ ...

Highlights in ER-positive breast cancer from SABCS 2025 include key metastatic and early-stage trial results from AMBRE, ...

Developmental exposure to endocrine disruptors is suspected to be one of the main factors responsible for the increased incidence of breast cancer in industrialized countries. New data published in ...

At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen-receptor degrader (SERD) giredestrant significantly reduced recurrence ...